Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients"

NCT07367555 is registered in ClinicalTrials.gov with Ariba Shafiq as lead sponsor.

NCT NCT07367555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07367555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients"
Lead sponsor
Ariba Shafiq
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2024
Completion date
March 31, 2025
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus